Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury

Completed

Conditions studied: Acquired Bleeding Disorder, Trauma

In brief

This study is conducted in North America. The purpose of this study is to evaluate the occurrence and severity of bleeding in brain injury and to identify important safety issues following traumatic brain injury.

Key facts

Study ID

NCT00124293

Run by

Novo Nordisk A/S

People needed

63

Starts

2004-10-06

Expected to finish

2005-11-23

Last updated by the study team

2017-02-27

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages Eligible for Study: 18 Years - 85 Years

Where it is running

• Novo Nordisk Investigational Site — Plainsboro, New Jersey, United States
• Novo Nordisk Investigational Site — Mississauga, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.